Literature DB >> 19086032

TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution.

Brian Bierie1, Agnieszka E Gorska, Daniel G Stover, Harold L Moses.   

Abstract

Transforming growth factor beta (TGF-beta) ligands are known to regulate virgin mammary development and contribute to initiation of post-lactation involution. However, the role for TGF-beta during the second phase of mammary involution has not been addressed. Previously, we have used an MMTV-Cre transgene to delete exon 2 from the Tgfbr2 gene in mammary epithelium, however we observed a gradual loss of T beta RII deficient epithelial cells that precluded an accurate study of the role for TGF-beta signaling during involution timepoints. Therefore, in order to determine the role for TGF-beta during the second phase of mammary involution we have now targeted T beta RII ablation within mammary epithelium using the WAP-Cre transgene [T beta RII(WKO)Rosa26R]. Our results demonstrated that TGF-beta regulates commitment to cell death during the second phase of mammary involution. Importantly, at day 3 of mammary involution the Na-Pi type IIb co-transporter (Npt2b), a selective marker for active lactation in luminal lobular alveolar epithelium, was completely silenced in the WAP-Cre control and T beta RII(WKO)Rosa26R tissues. However, by day 7 of involution the T beta RII(WKO)Rosa26R tissues had distended lobular alveoli and regained a robust Npt2b signal that was detected at the apical luminal surface. The Npt2b abundance and localization positively correlated with elevated WAP mRNA expression, suggesting that the distended alveoli were the result of an active lactation program rather than residual milk protein and lipid accumulation. In summary, the results suggest that an epithelial cell response to TGF-beta signaling regulates commitment to cell death and suppression of lactation during the second phase of mammary involution. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19086032      PMCID: PMC3038423          DOI: 10.1002/jcp.21646

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  40 in total

1.  Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.

Authors:  Yu-an Yang; Binwu Tang; Gertraud Robinson; Lothar Hennighausen; Steven G Brodie; Chu-Xia Deng; Lalage M Wakefield
Journal:  Cell Growth Differ       Date:  2002-03

2.  Conditional inactivation of the TGF-beta type II receptor using Cre:Lox.

Authors:  Anna Chytil; Mark A Magnuson; Christopher V E Wright; Harold L Moses
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

3.  Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli.

Authors:  Robin C Humphreys; Brian Bierie; Ling Zhao; Regina Raz; David Levy; Lothar Hennighausen
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

4.  Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice.

Authors:  K U Wagner; K McAllister; T Ward; B Davis; R Wiseman; L Hennighausen
Journal:  Transgenic Res       Date:  2001-12       Impact factor: 2.788

5.  Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation.

Authors:  Eftihia Cocolakis; Meiou Dai; Loren Drevet; Joanne Ho; Eric Haines; Suhad Ali; Jean-Jacques Lebrun
Journal:  J Biol Chem       Date:  2007-11-17       Impact factor: 5.157

6.  Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation.

Authors:  Kenneth B Ewan; Gopalan Shyamala; Shraddha A Ravani; Yang Tang; Rosemary Akhurst; Lalage Wakefield; Mary Helen Barcellos-Hoff
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

7.  Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution.

Authors:  A V Nguyen; J W Pollard
Journal:  Development       Date:  2000-07       Impact factor: 6.868

8.  Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

Authors:  E R Andrechek; W R Hardy; P M Siegel; M A Rudnicki; R D Cardiff; W J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

9.  Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation.

Authors:  Michelangelo Cordenonsi; Marco Montagner; Maddalena Adorno; Luca Zacchigna; Graziano Martello; Anant Mamidi; Sandra Soligo; Sirio Dupont; Stefano Piccolo
Journal:  Science       Date:  2007-01-18       Impact factor: 47.728

10.  Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium.

Authors:  K Miyoshi; J M Shillingford; G H Smith; S L Grimm; K U Wagner; T Oka; J M Rosen; G W Robinson; L Hennighausen
Journal:  J Cell Biol       Date:  2001-11-12       Impact factor: 10.539

View more
  21 in total

Review 1.  Differentiation of the mammary epithelial cell during involution: implications for breast cancer.

Authors:  Jenifer Monks; Peter M Henson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-05-01       Impact factor: 2.673

Review 2.  The role of activin in mammary gland development and oncogenesis.

Authors:  Karen A Dunphy; Alan L Schneyer; Mary J Hagen; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-08       Impact factor: 2.673

Review 3.  Hormonal regulation of the immune microenvironment in the mammary gland.

Authors:  Eleanor F Need; Vahid Atashgaran; Wendy V Ingman; Pallave Dasari
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-07-04       Impact factor: 2.673

Review 4.  TGF-beta biology in mammary development and breast cancer.

Authors:  Harold Moses; Mary Helen Barcellos-Hoff
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

5.  Singleminded-2s (Sim2s) promotes delayed involution of the mouse mammary gland through suppression of Stat3 and NFκB.

Authors:  Kelly C Scribner; Elizabeth A Wellberg; Richard P Metz; Weston W Porter
Journal:  Mol Endocrinol       Date:  2011-02-03

6.  Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression.

Authors:  Kathleen C Flanders; Lalage M Wakefield
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-25       Impact factor: 2.673

7.  Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancy.

Authors:  Wenyi Qin; Ke Zhang; Beth Kliethermes; Rachel L Ruhlen; Eva P Browne; Kathleen F Arcaro; Edward R Sauter
Journal:  BMC Cancer       Date:  2012-03-21       Impact factor: 4.430

8.  TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.

Authors:  Loay Kassem; Mathieu Deygas; Laurent Fattet; Jonathan Lopez; Thibaut Goulvent; Emilie Lavergne; Sylvie Chabaud; Nicolas Carrabin; Nicolas Chopin; Thomas Bachelot; Germain Gillet; Isabelle Treilleux; Ruth Rimokh
Journal:  BMC Cancer       Date:  2015-06-04       Impact factor: 4.430

9.  ATG proteins mediate efferocytosis and suppress inflammation in mammary involution.

Authors:  Irina Teplova; Fred Lozy; Sandy Price; Sukhwinder Singh; Nicola Barnard; Robert D Cardiff; Raymond B Birge; Vassiliki Karantza
Journal:  Autophagy       Date:  2013-02-04       Impact factor: 16.016

Review 10.  Mammary involution and breast cancer risk: transgenic models and clinical studies.

Authors:  Derek C Radisky; Lynn C Hartmann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-30       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.